Top Vaccines companies in Netherlands by EBITDA
This ranking features the top 5 Vaccines companies in Netherlands ranked by EBITDA, totaling a EBITDA of USD -670.47 M, for February 07, 2025.
Netherlands
Vaccines
EBITDA
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD -40.42 M
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
| 2 |
USD -106.90 M
|
Dec. 31, 2023 | USD 17.60 | -0.73% |
|
Netherlands |
|
| 3 |
USD -154.01 M
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
| 4 |
USD -176.86 M
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
| 5 |
USD -192.28 M
|
Dec. 31, 2023 | USD 667.09 | 1.81% |
|
Netherlands |
Frequently Asked Questions
-
Which Vaccines company in Netherlands has the highest EBITDA ?
The Vaccines company in Netherlands with the highest EBITDA is LAVA Therapeutics N.V. (NasdaqGS: LVTX) at USD -40.42 M.
-
Which Vaccines company in Netherlands has the lowest EBITDA ?
The Vaccines company in Netherlands with the lowest EBITDA is argenx SE (Brussels Stock Exchange: ARGX.BR) at USD -192.28 M.
-
What are the top 10 Vaccines companies in Netherlands by EBITDA ?
The top 10 Vaccines companies in Netherlands by EBITDA are LAVA Therapeutics N.V., Pharvaris N.V., Merus N.V., NewAmsterdam Pharma Company N.V. and argenx SE.
-
What are the bottom 10 Vaccines companies in Netherlands by EBITDA ?
The bottom 10 Vaccines companies in Netherlands by EBITDA are argenx SE, NewAmsterdam Pharma Company N.V., Merus N.V., Pharvaris N.V. and LAVA Therapeutics N.V..
